Hwa Kuang Biotech 2025 Q4 Financial Report
Hwa Kuang Biotech Co., Ltd. reported a net loss of NThBc179 million and basic EPS of NThBc2.68 for Q4 2025, with operating revenue reaching NT.839 billion.
📋 Article Processing Timeline
- 📰 Published: December 1, 2025 at 09:00
- 🔍 Collected: April 7, 2026 at 08:00 (3047h 0m after Published)
- 🤖 AI Analyzed: April 8, 2026 at 00:20 (16h 20m after Collected)
Company Code: 4737 Company Name: Hwa Kuang Biotech Co., Ltd. Industry: Biotechnology and Medical Industry Year/Quarter: 2025 Q4 Basic Earnings Per Share: NThBc2.68 Operating Revenue: NT.839 billion Net Income After Tax: NThBc179 million